Paul Song

Paul Song

Company: NKGen Biotech

Job title: Chief Executive Officer


Evaluating Adoptive Cellular Immunotherapy for Neurodegeneration with Autologous SNK01 2:30 pm

Enhancing natural killer cells to maximize the body’s ability to destroy diseased and abnormal cells Reviewing NK cell therapy as an alternative modality of treatment to resolve neurodegeneration with the body’s natural immune system Exploring phase 1 clinical safety and efficacy data of autologous SNK01 in treating neurodegenerative diseaseRead more

day: Translational Track Day 2 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.